Aligos Therapeutics's total assets for Q2 2025 were $134.71M, a decrease of -10.61% from the previous quarter. ALGS total liabilities were $32.84M for the fiscal quarter, a -4.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.